LIPID INCORPORATED SERUM-FREE MEDIUM
LIPID INCORPORATED SERUM-FREE MEDIUM
批准号:
3487562
负责人:
MENASHI A COHENFORD
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1986-07-31
中文摘要
该项目的长期目标是设计一种无血清
用于哺乳动物细胞体外最佳生长的化学成分确定的培养基。
该提案的具体目的是通过非常规方法,
载体蛋白、脂肪酸、α-硫辛酸、脂溶性
维生素和胆固醇在现有的无血清培养基,
培养基(CEM)。 除了激素、生长和附着因子外,
是最佳生长和最终产品生产的重要物质
哺乳动物细胞体外培养。 预计在I期研究期间,
将开发将脂肪酸,脂溶性维生素,
α-硫辛酸和胆固醇转化为CEM而不使用载体
proteins. 第二阶段的研究将集中在进一步改善CEM,
将有机和水溶性激素和生长因子掺入到
CEM。 一种无血清CEM,将优化细胞在体外的生长
将在研究和生物技术实验室中得到广泛应用。
这种产品的商业价值将是巨大的。
英文摘要
The long term objective of this project is to design a serum-free
chemically defined medium for optimum growth of mammalian cells in vitro.
The specific aim of this proposal is to solubilize, by means other than the
use of carrier proteins, fatty acids, alpha-lipoic acid, fat soluble
vitamins and cholesterol in an existent serum-free medium, Chee's Essential
Medium (CEM). Besides hormones, growth and attachment factors, lipids may
be important substances for optimum growth and production of end products
by mammalian cells in vitro. It is expected that during Phase I studies,
methods will be developed to incorporate fatty acids, fat-soluble vitamins,
alpha-lipoic acid and cholesterol into CEM without the use of carrier
proteins. Phase II studies will focus on further improvement of CEM by
incorporating organic and water-soluble hormones and growth facrors into
CEM. A serum-free CEM that will optimize the growth of cells in vitro
would find wide application in research and biotechnology laboratories.
The commercial value of such a product would be significant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Enzyme Linked Immunosorbent Assay (ELISA) for Monitoring Galactosemia
-
批准号:7327842
-
项目类别:
-
资助金额:$15.33万
-
财政年份:2007
-
负责人:MENASHI A COHENFORD
-
依托单位:
THINPREP HPV IN SITU HYBRIDIZATION WITH PNA PROBES
-
批准号:2776434
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:MENASHI A COHENFORD
-
依托单位:
LIPID-INCORPORATED SERUM-FREE MEDIUM
-
批准号:2049502
-
项目类别:
-
资助金额:$19.08万
-
财政年份:1987
-
负责人:MENASHI A COHENFORD
-
依托单位:
LIPID INCORPORATED SERUM-FREE-MEDIUM PHASE II
-
批准号:2049501
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1987
-
负责人:MENASHI A COHENFORD
-
依托单位:
国内基金
海外基金
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
-
批准号:82072798
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张丽
-
依托单位:
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
-
批准号:81302714
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:俞媛
-
依托单位: